Better Delivery Method for Glaucoma Drug

  • Author: ChemistryViews.org
  • Published: 26 June 2017
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: ACS Biomaterials Science & Engineering/ACS Publications
  • Associated Societies: American Chemical Society (ACS), USA
thumbnail image: Better Delivery Method for Glaucoma Drug

Glaucoma is an eye disease in which the pressure inside the eye is too high, which causes damage to the optic nerve and can result in blindness. Treatment usually involves drugs that lower this pressure, such as brimonidine tartrate (BT). These drugs are applied in the form of eye drops, which have to be used two or three times a day. This frequent need for application causes many patients to skip doses. In addition, only about 5 % of the active compound actually reaches the target tissue when eye drops are used.


Hu Yang, Virginia Commonwealth University, Richmond, USA, and colleagues have developed dendrimer-based nanofibers which can be applied to the eye in dry form, where they dissolve quickly and can deliver a drug. The team modified polyamidoamine (PAMAM) dendrimers by conjugating them with methoxy polyethylene glycol (mPEG). Then they used electrospinning to combine these dendrimers with poly(ethylene oxide) and BT into nanofiber mats.


The researchers tested the drug delivery properties and eye tolerance of the nanofiber mats in rats. They compared the results to regular BT eye drops and found that the mats were similarly safe and effective in a single application and dissolved rapidly. However, after three weeks of continued use, the dendrimer accumulated in the eye and the drug's efficacy was significantly improved. According to the team, there could be another reason for the improved results: In contrast to eyedrops, the dry application of the nanofiber mats makes it easier to actually get all of the drug into the eye without loss, which could be especially useful for pediatricians or veterinarians.


 

Article Views: 825

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH